NeuroDome key facts
- Developer and manufacturer of minimally invasive surgical equipment designed for neurosurgery.
- It has raised $14.5M; the latest was Later Stage VC ($14.5M) in Mar 2026.
- Notable investors include Suzhou Oriza Holdings Corporation, Shunwei Capital, Frees Fund, Optics Valley Industry Investment, Xi'an Finance Investment Management — 12 tracked in total.
- Status: Privately Held (backing).
Who backs NeuroDome
12+Membership and data by Private Market View
- ·The complete investor list: 12 names
- ·Watch NeuroDome: the Monday email on marks, rounds and moves
NeuroDome funding rounds
No funding rounds for NeuroDome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
NeuroDome investors
12 investors are on record for NeuroDome, including Suzhou Oriza Holdings Corporation, Shunwei Capital, Frees Fund and Optics Valley Industry Investment.
About NeuroDome
Developer and manufacturer of minimally invasive surgical equipment designed for neurosurgery. With non-invasive deep brain neuromodulation technology and other related technologies, the company's solutions include wearable medical instruments, medical imaging technology and medical information systems, enabling medical users to reduce the risk of neurosurgery.
- Sector
- Healthcare
- HQ
- Xi'an, China
- Founded
- 2019
- Employees
- 1
- Website
- neurodome-med.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
NeuroDome doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.